The Filing Desk

Alpha Pro Tech vs Insight Molecular Diagnostics

Alpha Pro Tech APT · Insight Molecular Diagnostics IMDX · Health Care Supplies

Alpha Pro Tech reported revenue of $59 million in fiscal 2025, 14.4 times Insight Molecular Diagnostics' $4 million in fiscal 2025. Alpha Pro Tech's revenue grew 2.2% in its latest year, and Insight Molecular Diagnostics' grew 115.6%. Alpha Pro Tech had an operating margin of 6.5%, against -1260.8% at Insight Molecular Diagnostics. Free cash flow was $2 million at Alpha Pro Tech and −$25 million at Insight Molecular Diagnostics.

Side by side

Alpha Pro TechInsight Molecular Diagnostics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$59M$4M
Revenue growth2.2%115.6%
Revenue growth a year, last 5 years−10.5%27.9%
Gross margin38.1%56.7%
Operating margin6.5%−1,260.8%
Net margin6.0%−1,238.5%
Free cash flow$2M−$25M
Free cash flow margin2.9%−625.6%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$3M$0M
Change in diluted share count−6.1%133.2%
Last close$6.24$1.66
P/E at the last close12.5×—
Insider trades, last 12 monthssold $417,209bought $11.7 million, sold $0
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Alpha Pro TechInsight Molecular Diagnostics
Operating margin
Percent of revenue
Alpha Pro TechInsight Molecular Diagnostics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Alpha Pro TechInsight Molecular Diagnostics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Alpha Pro Tech and Insight Molecular Diagnostics pages.